Francesca Reggiani

1.1k total citations
29 papers, 745 citations indexed

About

Francesca Reggiani is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Francesca Reggiani has authored 29 papers receiving a total of 745 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 13 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Francesca Reggiani's work include Metabolism, Diabetes, and Cancer (6 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Cancer, Lipids, and Metabolism (4 papers). Francesca Reggiani is often cited by papers focused on Metabolism, Diabetes, and Cancer (6 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Cancer, Lipids, and Metabolism (4 papers). Francesca Reggiani collaborates with scholars based in Italy, United States and France. Francesca Reggiani's co-authors include Francesco Bertolini, Alessia Ciarrocchi, Stefania Orecchioni, Giulia Gobbi, Valentina Sancisi, Giovanna Talarico, Patrizia Mancuso, Valentina Labanca, Giuliana Gregato and Angelica Calleri and has published in prestigious journals such as Nature Communications, Cancer Research and Oncogene.

In The Last Decade

Francesca Reggiani

27 papers receiving 739 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Francesca Reggiani Italy 14 414 229 171 150 86 29 745
Claudia A. Benavente United States 15 376 0.9× 209 0.9× 97 0.6× 73 0.5× 78 0.9× 24 709
Nehal S. Parikh United States 10 690 1.7× 89 0.4× 231 1.4× 205 1.4× 117 1.4× 21 987
Marc-André Déry Canada 9 465 1.1× 114 0.5× 288 1.7× 83 0.6× 65 0.8× 11 728
Cindy Hodakoski United States 10 864 2.1× 203 0.9× 315 1.8× 107 0.7× 91 1.1× 11 1.2k
Haruka Handa Japan 13 327 0.8× 179 0.8× 111 0.6× 97 0.6× 75 0.9× 22 564
Harald Schuhwerk Germany 8 442 1.1× 309 1.3× 230 1.3× 78 0.5× 79 0.9× 10 701
Atsushi Sato Japan 19 780 1.9× 230 1.0× 195 1.1× 123 0.8× 159 1.8× 44 1.1k
Nicholas Dean United States 11 682 1.6× 227 1.0× 107 0.6× 120 0.8× 51 0.6× 37 976
Kathryn M. Kinross Australia 9 409 1.0× 158 0.7× 88 0.5× 100 0.7× 54 0.6× 16 632
Jian Guan China 15 837 2.0× 233 1.0× 118 0.7× 107 0.7× 50 0.6× 25 1.0k

Countries citing papers authored by Francesca Reggiani

Since Specialization
Citations

This map shows the geographic impact of Francesca Reggiani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Reggiani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Reggiani more than expected).

Fields of papers citing papers by Francesca Reggiani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesca Reggiani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Reggiani. The network helps show where Francesca Reggiani may publish in the future.

Co-authorship network of co-authors of Francesca Reggiani

This figure shows the co-authorship network connecting the top 25 collaborators of Francesca Reggiani. A scholar is included among the top collaborators of Francesca Reggiani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesca Reggiani. Francesca Reggiani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Torricelli, Federica, Benedetta Donati, Veronica Manicardi, et al.. (2025). CDKN2A deletion is associated with immune desertification in diffuse pleural mesothelioma. Journal of Experimental & Clinical Cancer Research. 44(1). 256–256.
2.
Gugnoni, Mila, Veronica Manicardi, Federica Torricelli, et al.. (2025). RUNX2 cooperates with SREBP1 to rewire cancer metabolism and promote aggressiveness. Journal of Experimental & Clinical Cancer Research. 44(1). 298–298. 1 indexed citations
3.
Reggiani, Francesca, Giovanna Talarico, Giulia Gobbi, et al.. (2024). BET inhibitors drive Natural Killer activation in non-small cell lung cancer via BRD4 and SMAD3. Nature Communications. 15(1). 2567–2567. 9 indexed citations
4.
Pirone, Daniele, Lisa Miccio, Vittorio Bianco, et al.. (2024). Lightweight CNN efficiently discriminates ovarian cancer cells from a tumor microenvironment via holographic imaging flow cytometry. Biomedical Optics Express. 16(11). 4273–4273.
5.
Gobbi, Giulia, Federica Torricelli, Elisabetta Sauta, et al.. (2023). The long non-coding RNA TAZ-AS202 promotes lung cancer progression via regulation of the E2F1 transcription factor and activation of Ephrin signaling. Cell Death and Disease. 14(11). 752–752. 3 indexed citations
6.
Donati, Benedetta, Francesca Reggiani, Federica Torricelli, et al.. (2023). Spatial Distribution of Immune Cells Drives Resistance to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer. Cancer Immunology Research. 12(1). 120–134. 10 indexed citations
7.
Cortini, Margherita, Francesca Macchi, Francesca Reggiani, et al.. (2023). Endogenous Extracellular Matrix Regulates the Response of Osteosarcoma 3D Spheroids to Doxorubicin. Cancers. 15(4). 1221–1221. 20 indexed citations
8.
Lorenzini, Eugenia, Federica Torricelli, Raffaella Zamponi, et al.. (2022). KAP1 is a new non-genetic vulnerability of malignant pleural mesothelioma (MPM). NAR Cancer. 4(3). zcac024–zcac024. 1 indexed citations
9.
Gugnoni, Mila, Gloria Manzotti, Elisabetta Sauta, et al.. (2022). OVOL2 impairs RHO GTPase signaling to restrain mitosis and aggressiveness of Anaplastic Thyroid Cancer. Journal of Experimental & Clinical Cancer Research. 41(1). 108–108. 13 indexed citations
10.
Reggiani, Francesca, et al.. (2022). The multifaceted role of EGLN family prolyl hydroxylases in cancer: going beyond HIF regulation. Oncogene. 41(29). 3665–3679. 28 indexed citations
11.
Sauta, Elisabetta, Francesca Reggiani, Federica Torricelli, et al.. (2021). CSNK1A1, KDM2A, and LTB4R2 Are New Druggable Vulnerabilities in Lung Cancer. Cancers. 13(14). 3477–3477. 7 indexed citations
12.
Reggiani, Francesca, Giulia Gobbi, Alessia Ciarrocchi, & Valentina Sancisi. (2020). YAP and TAZ Are Not Identical Twins. Trends in Biochemical Sciences. 46(2). 154–168. 102 indexed citations
13.
Reggiani, Francesca, Giulia Gobbi, Alessia Ciarrocchi, Davide Carlo Ambrosetti, & Valentina Sancisi. (2020). Multiple roles and context-specific mechanisms underlying YAP and TAZ-mediated resistance to anti-cancer therapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1873(1). 188341–188341. 27 indexed citations
14.
Gobbi, Giulia, Benedetta Donati, Ítalo Faria do Valle, et al.. (2019). The Hippo pathway modulates resistance to BET proteins inhibitors in lung cancer cells. Oncogene. 38(42). 6801–6817. 55 indexed citations
15.
Reggiani, Francesca, et al.. (2018). Abstract 18: MMP9 inhibition in mouse models of breast cancer: Therapeutic synergy with vinorelbine-based chemotherapy. Cancer Research. 78(13_Supplement). 18–18. 2 indexed citations
16.
Reggiani, Francesca, Valentina Labanca, Patrizia Mancuso, et al.. (2017). Adipose Progenitor Cell Secretion of GM-CSF and MMP9 Promotes a Stromal and Immunological Microenvironment That Supports Breast Cancer Progression. Cancer Research. 77(18). 5169–5182. 65 indexed citations
17.
Talarico, Giovanna, Stefania Orecchioni, Katiuscia Dallaglio, et al.. (2016). Aspirin and atenolol enhance metformin activity against breast cancer by targeting both neoplastic and microenvironment cells. Scientific Reports. 6(1). 18673–18673. 45 indexed citations
18.
Allegretti, Matteo, Maria Rosaria Ricciardi, Roberto Licchetta, et al.. (2015). The pan-class I phosphatidyl-inositol-3 kinase inhibitor NVP-BKM120 demonstrates anti-leukemic activity in acute myeloid leukemia. Scientific Reports. 5(1). 18137–18137. 27 indexed citations
19.
Orecchioni, Stefania, Francesca Reggiani, Giovanna Talarico, et al.. (2014). The biguanides metformin and phenformin inhibit angiogenesis, local and metastatic growth of breast cancer by targeting both neoplastic and microenvironment cells. International Journal of Cancer. 136(6). E534–44. 120 indexed citations
20.
Orecchioni, Stefania, Giuliana Gregato, Inés Martín-Padura, et al.. (2013). Complementary Populations of Human Adipose CD34+ Progenitor Cells Promote Growth, Angiogenesis, and Metastasis of Breast Cancer. Cancer Research. 73(19). 5880–5891. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Claudia A. Benavente Breakdown of academic impact, for papers by Nehal S. Parikh Breakdown of academic impact, for papers by Marc-André Déry Breakdown of academic impact, for papers by Cindy Hodakoski Breakdown of academic impact, for papers by Haruka Handa Breakdown of academic impact, for papers by Harald Schuhwerk Breakdown of academic impact, for papers by Atsushi Sato Breakdown of academic impact, for papers by Nicholas Dean Breakdown of academic impact, for papers by Kathryn M. Kinross Breakdown of academic impact, for papers by Jian Guan
Rankless by CCL
2026